- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 213/26 - Radicaux substitués par des atomes d'halogènes ou par des radicaux nitro
Détention brevets de la classe C07D 213/26
Brevets de cette classe: 219
Historique des publications depuis 10 ans
|
20
|
17
|
12
|
14
|
8
|
12
|
15
|
9
|
9
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Dow AgroSciences LLC | 1188 |
8 |
| Novartis AG | 10262 |
6 |
| Mycovia Pharmaceuticals, Inc. | 40 |
6 |
| Merck Sharp & Dohme LLC | 3734 |
6 |
| UDC Ireland Limited | 508 |
5 |
| Agc, Inc. | 5524 |
5 |
| Sumitomo Chemical Company, Limited | 9016 |
4 |
| The Regents of the University of Michigan | 4985 |
4 |
| Essilor International (compagnie Generale D'optique) | 2994 |
4 |
| Nankai University | 261 |
4 |
| Rigel Pharmaceuticals, Inc. | 507 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
4 |
| Corteva Agriscience LLC | 2648 |
4 |
| Bristol-myers Squibb Company | 4742 |
3 |
| Samsung Display Co., Ltd. | 38627 |
3 |
| Daikin Industries, Ltd. | 10499 |
3 |
| FMC Corporation | 807 |
3 |
| Osaka University | 3267 |
3 |
| The United States of America, as represented by the Secretary, Department of Health & Human Services | 219 |
3 |
| Universal Display Corporation | 2085 |
3 |
| Autres propriétaires | 134 |